A new antibody shot that protects babies against RSV infection could be struggling to gain traction, Philadelphia researchers ...

The U.S. Centers for Disease Control and Prevention is warning physicians that cases of respiratory syncytial virus, or RSV, are rising in the South, and that the regional increase may portend ...

The RSV hospitalization rate among seniors in the most recent season was higher than it’s been for at least six years, according to data from the CDC. There were also high levels of flu, and ...

The first vaccines to guard against the respiratory illness RSV will soon be available for some older adults, ages 60 and over, after the CDC formally backed recommendations for the shots.

CDC panel recommends new RSV shot for babies and certain toddlers. ... A federal advisory committee has voted unanimously to recommend a new drug to prevent severe respiratory syncytial virus, ...

In April, the CDC’s influential Advisory Committee on Immunization Practices recommended expanding RSV vaccination to ...

In Georgia, RSV-linked hospitalizations among those under age 4 have risen from 2.0 per 100,000 for the week ending Aug. 5 to 7.0 per 100,000 for the week ending Aug. 19, the CDC said.

A Centers for Disease Control and Prevention health advisory notes elevated cases of respiratory syncytial virus in parts of the Southeastern U.S. RSV season may have already begun, CDC warns ...

RSV is the leading cause of hospitalization for infants in the U.S. Each year, the virus is associated with some 1.5 million medical visits, 60,000 to 80,000 hospitalizations, and up to 300 deaths ...

New CDC recommendations for RSV vaccinations in adults over 75 and high-risk adults 60-74 aim to protect against severe illness and simplify decision-making. Skip to main content. BHR; ...

From Aug. 5 through Aug. 19, the rate of RSV-related hospitalizations increased from 2 in 100,000 kids ages 4 and younger, to 7 per 100,000, the CDC reported.

In April, the CDC’s influential Advisory Committee on Immunization Practices recommended expanding RSV vaccination to high-risk adults as young as 50, too.